Company intelligence / Profile preview

BioXpert

Ghent, East Flanders, Belgium

Ownership: Private
Development stage: Other

Overview

BioXpert is a specialized provider of bioprocess control and automation software, now integrated into the Getinge Life Science portfolio following the acquisition of Applikon Biotechnology. The company focuses on developing sophisticated monitoring and data management systems for bioreactors, enabling researchers and manufacturers to optimize cell culture and fermentation processes. Its flagship software, BioXpert, is widely utilized in the biotechnology and pharmaceutical industries for real-time process control, data acquisition, and ensuring regulatory compliance (21 CFR Part 11). By providing advanced automation solutions, BioXpert helps streamline bioproduction from laboratory research to industrial scale-up.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Applikon Biotechnology

Beyond the preview

Go deeper on BioXpert.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioXpert.

Explore the full profile